Controlled Equity OfferingSM Sales AgreementEyePoint Pharmaceuticals, Inc. • August 5th, 2020 • Laboratory analytical instruments • New York
Company FiledAugust 5th, 2020 Industry JurisdictionEyePoint Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: